Daniel Tan - EUDA Health Chief Officer
| EUDAW Stock | 0.27 0.06 28.57% |
Insider
Daniel Tan is Chief Officer of EUDA Health Holdings
| Age | 43 |
| Address | 1 Pemimpin Drive #12-07, Singapore, Singapore, 576151 |
| Phone | 65 6268 6821 |
| Web | https://euda.com |
EUDA Health Management Efficiency
The company has return on total asset (ROA) of (1.8031) % which means that it has lost $1.8031 on every $100 spent on assets. This is way below average. EUDA Health's management efficiency ratios could be used to measure how well EUDA Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, EUDA Health's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 6.68 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.06). At this time, EUDA Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 30.2 M in 2024, whereas Other Current Assets are likely to drop slightly above 190.4 K in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Burton | Health Catalyst | 48 | |
| Tyson Murdock | HealthEquity | 53 | |
| Lia Wallick | Augmedix | N/A | |
| Barrie Brian | Akili Inc | N/A | |
| Emmanuel Krakaris | Augmedix | 65 | |
| Jonathan Hawkins | Augmedix | 54 | |
| Santosh Shanbhag | Akili Inc | 47 | |
| Carl Gottlieb | Akili Inc | N/A | |
| Sandra Breber | Augmedix | 66 | |
| Amy Sebero | Streamline Health Solutions | N/A | |
| Scott Kollins | Akili Inc | N/A | |
| Paul Ginocchio | Augmedix | 54 | |
| MB CCS | Streamline Health Solutions | N/A | |
| David Terrell | Forian Inc | N/A | |
| Ian Shakil | Augmedix | 39 | |
| Jona Raasch | National Research Corp | 65 | |
| Mark Grove | Forian Inc | N/A | |
| Michael Vesey | Forian Inc | 62 | |
| Dave Ross | Health Catalyst | N/A | |
| Matthew Omernick | Akili Inc | N/A | |
| Jason Alger | Health Catalyst | 40 | |
Management Performance
| Return On Asset | -1.8 |
EUDA Health Holdings Leadership Team
Elected by the shareholders, the EUDA Health's board of directors comprises two types of representatives: EUDA Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EUDA. The board's role is to monitor EUDA Health's management team and ensure that shareholders' interests are well served. EUDA Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EUDA Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wei Chen, CEO Director | ||
| Steven Sobak, Chief Officer | ||
| Daniel Tan, Chief Officer | ||
| Alfred Lim, Executive Director | ||
| Jenifer Goh, President Operations |
EUDA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EUDA Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.8 | ||||
| Operating Margin | (1.75) % | ||||
| Number Of Shares Shorted | 18.14 K | ||||
| Revenue | 9.84 M | ||||
| EBITDA | (18.25 M) | ||||
| Net Income | (24.95 M) | ||||
| Total Debt | 3.88 M | ||||
| Book Value Per Share | (0.90) X | ||||
| Cash Flow From Operations | (1.53 M) | ||||
| Number Of Employees | 150 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EUDA Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EUDA Health's short interest history, or implied volatility extrapolated from EUDA Health options trading.
Pair Trading with EUDA Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EUDA Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EUDA Health will appreciate offsetting losses from the drop in the long position's value.Moving against EUDA Stock
| 0.82 | LUCD | Lucid Diagnostics Financial Report 20th of May 2024 | PairCorr |
| 0.8 | IART | Integra LifeSciences | PairCorr |
| 0.8 | MASS | 908 Devices Financial Report 14th of May 2024 | PairCorr |
| 0.78 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.75 | INMD | InMode | PairCorr |
The ability to find closely correlated positions to EUDA Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EUDA Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EUDA Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EUDA Health Holdings to buy it.
The correlation of EUDA Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EUDA Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EUDA Health Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EUDA Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the EUDA Health Holdings information on this page should be used as a complementary analysis to other EUDA Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for EUDA Stock analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is EUDA Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.42 | Quarterly Revenue Growth (0.54) | Return On Assets (1.80) |
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.